sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Point of Care Infectious Disease Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Point of Care Infectious Disease Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Category : Pharmaceuticals and Healthcare QY Research Pages :131
Published Date : 2020-12-15

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Point of Care Infectious Disease Market with our analysts monitoring the situation across the globe.
Point of Care Infectious Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Point of Care Infectious Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. The key players covered in this study Siemens Healthineers Trivitron Healthcare F. Hoffmann-La Roche Ltd Abbott Quest Diagnostics, Inc BD & Company Chembio Diagnostics Inc Trinity Biotech Cardinal Health Bio-Rad Labs Inc. bioMérieux SA Thermo Fisher Scientific Inc Sight Diagnostics Ltd. Gene POC Ortho-Clinical Diagnostics OJ-Bio Ltd. Market segment by Type, the product can be split into HIV POC Clostridium difficile POC HBV POC Pneumonia or Streptococcus associated infections Respiratory syncytial virus (RSV) POC HPV POC Influenza/Flu POC HCV POC MRSA POC TB and drug-resistant TB POC Market segment by Application, split into Hospitals Clinics Home Assisted Living Healthcare Facilities Laboratories Others Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Point of Care Infectious Disease Revenue 1.4 Market by Type 1.4.1 Global Point of Care Infectious Disease Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 HIV POC 1.4.3 Clostridium difficile POC 1.4.4 HBV POC 1.4.5 Pneumonia or Streptococcus associated infections 1.4.6 Respiratory syncytial virus (RSV) POC 1.4.7 HPV POC 1.4.8 Influenza/Flu POC 1.4.9 HCV POC 1.4.10 MRSA POC 1.4.11 TB and drug-resistant TB POC 1.5 Market by Application 1.5.1 Global Point of Care Infectious Disease Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Home 1.5.5 Assisted Living Healthcare Facilities 1.5.6 Laboratories 1.5.7 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Global Point of Care Infectious Disease Market Perspective (2015-2026) 2.2 Global Point of Care Infectious Disease Growth Trends by Regions 2.2.1 Point of Care Infectious Disease Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Point of Care Infectious Disease Historic Market Share by Regions (2015-2020) 2.2.3 Point of Care Infectious Disease Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Point of Care Infectious Disease Market Growth Strategy 2.3.6 Primary Interviews with Key Point of Care Infectious Disease Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Point of Care Infectious Disease Players by Market Size 3.1.1 Global Top Point of Care Infectious Disease Players by Revenue (2015-2020) 3.1.2 Global Point of Care Infectious Disease Revenue Market Share by Players (2015-2020) 3.1.3 Global Point of Care Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Point of Care Infectious Disease Market Concentration Ratio 3.2.1 Global Point of Care Infectious Disease Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Point of Care Infectious Disease Revenue in 2019 3.3 Point of Care Infectious Disease Key Players Head office and Area Served 3.4 Key Players Point of Care Infectious Disease Product Solution and Service 3.5 Date of Enter into Point of Care Infectious Disease Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Point of Care Infectious Disease Historic Market Size by Type (2015-2020) 4.2 Global Point of Care Infectious Disease Forecasted Market Size by Type (2021-2026) 5 Market Size by Application (2015-2026) 5.1 Global Point of Care Infectious Disease Market Size by Application (2015-2020) 5.2 Global Point of Care Infectious Disease Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Point of Care Infectious Disease Market Size (2015-2020) 6.2 Point of Care Infectious Disease Key Players in North America (2019-2020) 6.3 North America Point of Care Infectious Disease Market Size by Type (2015-2020) 6.4 North America Point of Care Infectious Disease Market Size by Application (2015-2020) 7 Europe 7.1 Europe Point of Care Infectious Disease Market Size (2015-2020) 7.2 Point of Care Infectious Disease Key Players in Europe (2019-2020) 7.3 Europe Point of Care Infectious Disease Market Size by Type (2015-2020) 7.4 Europe Point of Care Infectious Disease Market Size by Application (2015-2020) 8 China 8.1 China Point of Care Infectious Disease Market Size (2015-2020) 8.2 Point of Care Infectious Disease Key Players in China (2019-2020) 8.3 China Point of Care Infectious Disease Market Size by Type (2015-2020) 8.4 China Point of Care Infectious Disease Market Size by Application (2015-2020) 9 Japan 9.1 Japan Point of Care Infectious Disease Market Size (2015-2020) 9.2 Point of Care Infectious Disease Key Players in Japan (2019-2020) 9.3 Japan Point of Care Infectious Disease Market Size by Type (2015-2020) 9.4 Japan Point of Care Infectious Disease Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Point of Care Infectious Disease Market Size (2015-2020) 10.2 Point of Care Infectious Disease Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Point of Care Infectious Disease Market Size by Type (2015-2020) 10.4 Southeast Asia Point of Care Infectious Disease Market Size by Application (2015-2020) 11 India 11.1 India Point of Care Infectious Disease Market Size (2015-2020) 11.2 Point of Care Infectious Disease Key Players in India (2019-2020) 11.3 India Point of Care Infectious Disease Market Size by Type (2015-2020) 11.4 India Point of Care Infectious Disease Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Point of Care Infectious Disease Market Size (2015-2020) 12.2 Point of Care Infectious Disease Key Players in Central & South America (2019-2020) 12.3 Central & South America Point of Care Infectious Disease Market Size by Type (2015-2020) 12.4 Central & South America Point of Care Infectious Disease Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Siemens Healthineers 13.1.1 Siemens Healthineers Company Details 13.1.2 Siemens Healthineers Business Overview 13.1.3 Siemens Healthineers Point of Care Infectious Disease Introduction 13.1.4 Siemens Healthineers Revenue in Point of Care Infectious Disease Business (2015-2020)) 13.1.5 Siemens Healthineers Recent Development 13.2 Trivitron Healthcare 13.2.1 Trivitron Healthcare Company Details 13.2.2 Trivitron Healthcare Business Overview 13.2.3 Trivitron Healthcare Point of Care Infectious Disease Introduction 13.2.4 Trivitron Healthcare Revenue in Point of Care Infectious Disease Business (2015-2020) 13.2.5 Trivitron Healthcare Recent Development 13.3 F. Hoffmann-La Roche Ltd 13.3.1 F. Hoffmann-La Roche Ltd Company Details 13.3.2 F. Hoffmann-La Roche Ltd Business Overview 13.3.3 F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Introduction 13.3.4 F. Hoffmann-La Roche Ltd Revenue in Point of Care Infectious Disease Business (2015-2020) 13.3.5 F. Hoffmann-La Roche Ltd Recent Development 13.4 Abbott 13.4.1 Abbott Company Details 13.4.2 Abbott Business Overview 13.4.3 Abbott Point of Care Infectious Disease Introduction 13.4.4 Abbott Revenue in Point of Care Infectious Disease Business (2015-2020) 13.4.5 Abbott Recent Development 13.5 Quest Diagnostics, Inc 13.5.1 Quest Diagnostics, Inc Company Details 13.5.2 Quest Diagnostics, Inc Business Overview 13.5.3 Quest Diagnostics, Inc Point of Care Infectious Disease Introduction 13.5.4 Quest Diagnostics, Inc Revenue in Point of Care Infectious Disease Business (2015-2020) 13.5.5 Quest Diagnostics, Inc Recent Development 13.6 BD & Company 13.6.1 BD & Company Company Details 13.6.2 BD & Company Business Overview 13.6.3 BD & Company Point of Care Infectious Disease Introduction 13.6.4 BD & Company Revenue in Point of Care Infectious Disease Business (2015-2020) 13.6.5 BD & Company Recent Development 13.7 Chembio Diagnostics Inc 13.7.1 Chembio Diagnostics Inc Company Details 13.7.2 Chembio Diagnostics Inc Business Overview 13.7.3 Chembio Diagnostics Inc Point of Care Infectious Disease Introduction 13.7.4 Chembio Diagnostics Inc Revenue in Point of Care Infectious Disease Business (2015-2020) 13.7.5 Chembio Diagnostics Inc Recent Development 13.8 Trinity Biotech 13.8.1 Trinity Biotech Company Details 13.8.2 Trinity Biotech Business Overview 13.8.3 Trinity Biotech Point of Care Infectious Disease Introduction 13.8.4 Trinity Biotech Revenue in Point of Care Infectious Disease Business (2015-2020) 13.8.5 Trinity Biotech Recent Development 13.9 Cardinal Health 13.9.1 Cardinal Health Company Details 13.9.2 Cardinal Health Business Overview 13.9.3 Cardinal Health Point of Care Infectious Disease Introduction 13.9.4 Cardinal Health Revenue in Point of Care Infectious Disease Business (2015-2020) 13.9.5 Cardinal Health Recent Development 13.10 Bio-Rad Labs Inc. 13.10.1 Bio-Rad Labs Inc. Company Details 13.10.2 Bio-Rad Labs Inc. Business Overview 13.10.3 Bio-Rad Labs Inc. Point of Care Infectious Disease Introduction 13.10.4 Bio-Rad Labs Inc. Revenue in Point of Care Infectious Disease Business (2015-2020) 13.10.5 Bio-Rad Labs Inc. Recent Development 13.11 bioMérieux SA 10.11.1 bioMérieux SA Company Details 10.11.2 bioMérieux SA Business Overview 10.11.3 bioMérieux SA Point of Care Infectious Disease Introduction 10.11.4 bioMérieux SA Revenue in Point of Care Infectious Disease Business (2015-2020) 10.11.5 bioMérieux SA Recent Development 13.12 Thermo Fisher Scientific Inc 10.12.1 Thermo Fisher Scientific Inc Company Details 10.12.2 Thermo Fisher Scientific Inc Business Overview 10.12.3 Thermo Fisher Scientific Inc Point of Care Infectious Disease Introduction 10.12.4 Thermo Fisher Scientific Inc Revenue in Point of Care Infectious Disease Business (2015-2020) 10.12.5 Thermo Fisher Scientific Inc Recent Development 13.13 Sight Diagnostics Ltd. 10.13.1 Sight Diagnostics Ltd. Company Details 10.13.2 Sight Diagnostics Ltd. Business Overview 10.13.3 Sight Diagnostics Ltd. Point of Care Infectious Disease Introduction 10.13.4 Sight Diagnostics Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020) 10.13.5 Sight Diagnostics Ltd. Recent Development 13.14 Gene POC 10.14.1 Gene POC Company Details 10.14.2 Gene POC Business Overview 10.14.3 Gene POC Point of Care Infectious Disease Introduction 10.14.4 Gene POC Revenue in Point of Care Infectious Disease Business (2015-2020) 10.14.5 Gene POC Recent Development 13.15 Ortho-Clinical Diagnostics 10.15.1 Ortho-Clinical Diagnostics Company Details 10.15.2 Ortho-Clinical Diagnostics Business Overview 10.15.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Introduction 10.15.4 Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Business (2015-2020) 10.15.5 Ortho-Clinical Diagnostics Recent Development 13.16 OJ-Bio Ltd. 10.16.1 OJ-Bio Ltd. Company Details 10.16.2 OJ-Bio Ltd. Business Overview 10.16.3 OJ-Bio Ltd. Point of Care Infectious Disease Introduction 10.16.4 OJ-Bio Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020) 10.16.5 OJ-Bio Ltd. Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

Get Free Sample

List of Tables Table 1. Point of Care Infectious Disease Key Market Segments Table 2. Key Players Covered: Ranking by Point of Care Infectious Disease Revenue Table 3. Ranking of Global Top Point of Care Infectious Disease Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Point of Care Infectious Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of HIV POC Table 6. Key Players of Clostridium difficile POC Table 7. Key Players of HBV POC Table 8. Key Players of Pneumonia or Streptococcus associated infections Table 9. Key Players of Respiratory syncytial virus (RSV) POC Table 10. Key Players of HPV POC Table 11. Key Players of Influenza/Flu POC Table 12. Key Players of HCV POC Table 13. Key Players of MRSA POC Table 14. Key Players of TB and drug-resistant TB POC Table 15. Global Point of Care Infectious Disease Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 16. Global Point of Care Infectious Disease Market Size by Regions (US$ Million): 2020 VS 2026 Table 17. Global Point of Care Infectious Disease Market Size by Regions (2015-2020) (US$ Million) Table 18. Global Point of Care Infectious Disease Market Share by Regions (2015-2020) Table 19. Global Point of Care Infectious Disease Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 20. Global Point of Care Infectious Disease Market Share by Regions (2021-2026) Table 21. Market Top Trends Table 22. Key Drivers: Impact Analysis Table 23. Key Challenges Table 24. Point of Care Infectious Disease Market Growth Strategy Table 25. Main Points Interviewed from Key Point of Care Infectious Disease Players Table 26. Global Point of Care Infectious Disease Revenue by Players (2015-2020) (Million US$) Table 27. Global Point of Care Infectious Disease Market Share by Players (2015-2020) Table 28. Global Top Point of Care Infectious Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Infectious Disease as of 2019) Table 29. Global Point of Care Infectious Disease by Players Market Concentration Ratio (CR5 and HHI) Table 30. Key Players Headquarters and Area Served Table 31. Key Players Point of Care Infectious Disease Product Solution and Service Table 32. Date of Enter into Point of Care Infectious Disease Market Table 33. Mergers & Acquisitions, Expansion Plans Table 34. Global Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$) Table 35. Global Point of Care Infectious Disease Market Size Share by Type (2015-2020) Table 36. Global Point of Care Infectious Disease Revenue Market Share by Type (2021-2026) Table 37. Global Point of Care Infectious Disease Market Size Share by Application (2015-2020) Table 38. Global Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$) Table 39. Global Point of Care Infectious Disease Market Size Share by Application (2021-2026) Table 40. North America Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$) Table 41. North America Key Players Point of Care Infectious Disease Market Share (2019-2020) Table 42. North America Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$) Table 43. North America Point of Care Infectious Disease Market Share by Type (2015-2020) Table 44. North America Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$) Table 45. North America Point of Care Infectious Disease Market Share by Application (2015-2020) Table 46. Europe Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$) Table 47. Europe Key Players Point of Care Infectious Disease Market Share (2019-2020) Table 48. Europe Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$) Table 49. Europe Point of Care Infectious Disease Market Share by Type (2015-2020) Table 50. Europe Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$) Table 51. Europe Point of Care Infectious Disease Market Share by Application (2015-2020) Table 52. China Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$) Table 53. China Key Players Point of Care Infectious Disease Market Share (2019-2020) Table 54. China Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$) Table 55. China Point of Care Infectious Disease Market Share by Type (2015-2020) Table 56. China Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$) Table 57. China Point of Care Infectious Disease Market Share by Application (2015-2020) Table 58. Japan Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$) Table 59. Japan Key Players Point of Care Infectious Disease Market Share (2019-2020) Table 60. Japan Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$) Table 61. Japan Point of Care Infectious Disease Market Share by Type (2015-2020) Table 62. Japan Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$) Table 63. Japan Point of Care Infectious Disease Market Share by Application (2015-2020) Table 64. Southeast Asia Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$) Table 65. Southeast Asia Key Players Point of Care Infectious Disease Market Share (2019-2020) Table 66. Southeast Asia Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$) Table 67. Southeast Asia Point of Care Infectious Disease Market Share by Type (2015-2020) Table 68. Southeast Asia Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$) Table 69. Southeast Asia Point of Care Infectious Disease Market Share by Application (2015-2020) Table 70. India Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$) Table 71. India Key Players Point of Care Infectious Disease Market Share (2019-2020) Table 72. India Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$) Table 73. India Point of Care Infectious Disease Market Share by Type (2015-2020) Table 74. India Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$) Table 75. India Point of Care Infectious Disease Market Share by Application (2015-2020) Table 76. Central & South America Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$) Table 77. Central & South America Key Players Point of Care Infectious Disease Market Share (2019-2020) Table 78. Central & South America Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$) Table 79. Central & South America Point of Care Infectious Disease Market Share by Type (2015-2020) Table 80. Central & South America Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$) Table 81. Central & South America Point of Care Infectious Disease Market Share by Application (2015-2020) Table 82. Siemens Healthineers Company Details Table 83. Siemens Healthineers Business Overview Table 84. Siemens Healthineers Product Table 85. Siemens Healthineers Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$) Table 86. Siemens Healthineers Recent Development Table 87. Trivitron Healthcare Company Details Table 88. Trivitron Healthcare Business Overview Table 89. Trivitron Healthcare Product Table 90. Trivitron Healthcare Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$) Table 91. Trivitron Healthcare Recent Development Table 92. F. Hoffmann-La Roche Ltd Company Details Table 93. F. Hoffmann-La Roche Ltd Business Overview Table 94. F. Hoffmann-La Roche Ltd Product Table 95. F. Hoffmann-La Roche Ltd Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$) Table 96. F. Hoffmann-La Roche Ltd Recent Development Table 97. Abbott Company Details Table 98. Abbott Business Overview Table 99. Abbott Product Table 100. Abbott Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$) Table 101. Abbott Recent Development Table 102. Quest Diagnostics, Inc Company Details Table 103. Quest Diagnostics, Inc Business Overview Table 104. Quest Diagnostics, Inc Product Table 105. Quest Diagnostics, Inc Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$) Table 106. Quest Diagnostics, Inc Recent Development Table 107. BD & Company Company Details Table 108. BD & Company Business Overview Table 109. BD & Company Product Table 110. BD & Company Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$) Table 111. BD & Company Recent Development Table 112. Chembio Diagnostics Inc Company Details Table 113. Chembio Diagnostics Inc Business Overview Table 114. Chembio Diagnostics Inc Product Table 115. Chembio Diagnostics Inc Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$) Table 116. Chembio Diagnostics Inc Recent Development Table 117. Trinity Biotech Business Overview Table 118. Trinity Biotech Product Table 119. Trinity Biotech Company Details Table 120. Trinity Biotech Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$) Table 121. Trinity Biotech Recent Development Table 122. Cardinal Health Company Details Table 123. Cardinal Health Business Overview Table 124. Cardinal Health Product Table 125. Cardinal Health Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$) Table 126. Cardinal Health Recent Development Table 127. Bio-Rad Labs Inc. Company Details Table 128. Bio-Rad Labs Inc. Business Overview Table 129. Bio-Rad Labs Inc. Product Table 130. Bio-Rad Labs Inc. Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$) Table 131. Bio-Rad Labs Inc. Recent Development Table 132. bioMérieux SA Company Details Table 133. bioMérieux SA Business Overview Table 134. bioMérieux SA Product Table 135. bioMérieux SA Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$) Table 136. bioMérieux SA Recent Development Table 137. Thermo Fisher Scientific Inc Company Details Table 138. Thermo Fisher Scientific Inc Business Overview Table 139. Thermo Fisher Scientific Inc Product Table 140. Thermo Fisher Scientific Inc Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$) Table 141. Thermo Fisher Scientific Inc Recent Development Table 142. Sight Diagnostics Ltd. Company Details Table 143. Sight Diagnostics Ltd. Business Overview Table 144. Sight Diagnostics Ltd. Product Table 145. Sight Diagnostics Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$) Table 146. Sight Diagnostics Ltd. Recent Development Table 147. Gene POC Company Details Table 148. Gene POC Business Overview Table 149. Gene POC Product Table 150. Gene POC Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$) Table 151. Gene POC Recent Development Table 152. Ortho-Clinical Diagnostics Company Details Table 153. Ortho-Clinical Diagnostics Business Overview Table 154. Ortho-Clinical Diagnostics Product Table 155. Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$) Table 156. Ortho-Clinical Diagnostics Recent Development Table 157. OJ-Bio Ltd. Company Details Table 158. OJ-Bio Ltd. Business Overview Table 159. OJ-Bio Ltd. Product Table 160. OJ-Bio Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$) Table 161. OJ-Bio Ltd. Recent Development Table 162. Research Programs/Design for This Report Table 163. Key Data Information from Secondary Sources Table 164. Key Data Information from Primary Sources List of Figures Figure 1. Global Point of Care Infectious Disease Market Share by Type: 2020 VS 2026 Figure 2. HIV POC Features Figure 3. Clostridium difficile POC Features Figure 4. HBV POC Features Figure 5. Pneumonia or Streptococcus associated infections Features Figure 6. Respiratory syncytial virus (RSV) POC Features Figure 7. HPV POC Features Figure 8. Influenza/Flu POC Features Figure 9. HCV POC Features Figure 10. MRSA POC Features Figure 11. TB and drug-resistant TB POC Features Figure 12. Global Point of Care Infectious Disease Market Share by Application: 2020 VS 2026 Figure 13. Hospitals Case Studies Figure 14. Clinics Case Studies Figure 15. Home Case Studies Figure 16. Assisted Living Healthcare Facilities Case Studies Figure 17. Laboratories Case Studies Figure 18. Others Case Studies Figure 19. Point of Care Infectious Disease Report Years Considered Figure 20. Global Point of Care Infectious Disease Market Size YoY Growth 2015-2026 (US$ Million) Figure 21. Global Point of Care Infectious Disease Market Share by Regions: 2020 VS 2026 Figure 22. Global Point of Care Infectious Disease Market Share by Regions (2021-2026) Figure 23. Porter's Five Forces Analysis Figure 24. Global Point of Care Infectious Disease Market Share by Players in 2019 Figure 25. Global Top Point of Care Infectious Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Infectious Disease as of 2019 Figure 26. The Top 10 and 5 Players Market Share by Point of Care Infectious Disease Revenue in 2019 Figure 27. North America Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 28. Europe Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 29. China Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 30. Japan Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 31. Southeast Asia Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 32. India Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 33. Central & South America Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 34. Bottom-up and Top-down Approaches for This Report Figure 35. Data Triangulation Figure 36. Key Executives Interviewed

Get Free Sample

Related Reports

Global Point of Care Infectious Disease Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Point of Care Infectious Disease Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Point of Care Infectious Disease Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Point of Care Infectious Disease Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Point of Care Infectious Disease Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)